Home> Products> Inhibitors> 4SC-203-CAS 895533-09-2
price inquiry for CAS:895533-09-2, Product:4SC-203

4SC-203 CAS: 895533-09-2

Category: Inhibitors
Product Name: 4SC-203
Cat No: I000080
CAS No: 895533-09-2
Synonyms: SC71710
Molecular Formula: C33H38N8O4S
Molecular Weight: 642.77
SMILES: O=C(NC1=NC2=CC=C(NC3=C4C=C(OC)C(OCCCN5CCN(C)CC5)=CC4=NC=N3)C=C2S1)NC6=CC(C)=CC=C6OC
InChI: InChI=1S/C33H38N8O4S/c1-21-6-9-27(43-3)26(16-21)37-32(42)39-33-38-24-8-7-22(17-30(24)46-33)36-31-23-18-28(44-4)29(19-25(23)34-20-35-31)45-15-5-10-41-13-11-40(2)12-14-41/h6-9,16-20H,5,10-15H2,1-4H3,(H,34,35,36)(H2,37,38,39,42)
InChIKey: MAFACRSJGNJHCF-UHFFFAOYSA-N
Solubility: Soluble in DMSO, not in water
Target: Multikinase inhibitor
CAS 895533-09-2,4SC-203
  • Description

4SC-203(SC71710, cas 895533-09-2) is a multikinase inhibitor with potential antineoplastic activity. Multikinase inhibitor 4SC-203 selectively inhibits FMS-related tyrosine kinase 3 (FLT3/STK1), FLT3 mutated forms, and vascular endothelial growth factor receptors (VEGFRs). This may result in the inhibition of angiogenesis and cell proliferation in tumor cells in which these kinases are upregulated. FLT3 (FLK2), a class III tyrosine kinase receptor, is overexpressed or mutated in most B lineage and acute myeloid leukemias (AML). VEGFRs, tyrosine kinase receptors, are overexpressed in a variety of tumor cell types and play key roles in angiogenesis. 4SC-203 had been in Phase I clinical study, however, this study was discontinued.

  • Spec

Appearance:Solid powder
Purity: > 98%

  • References


1: Williams R. Discontinued in 2013: oncology drugs. Expert Opin Investig Drugs. 2015 Jan;24(1):95-110. Epub 2014 Oct 14. PubMed PMID: 25315907.


price inquiry for CAS:895533-09-2, Product:4SC-203